AHL Partners’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.1M Sell
36,246
-72,730
-67% -$3.83M 0.03% 708
2017
Q3
$4.89M Sell
108,976
-67,743
-38% -$2.81M 0.09% 411
2017
Q2
$6.98M Buy
176,719
+31,401
+22% +$1.29M 0.15% 231
2017
Q1
$5.89M Buy
145,318
+131,918
+984% +$5.15M 0.13% 282
2016
Q4
$538K Sell
13,400
-2,019
-13% -$76.1K 0.02% 809
2016
Q3
$558K Sell
15,419
-36,434
-70% -$1.25M 0.02% 800
2016
Q2
$1.5M Buy
51,853
+44,597
+615% +$1.35M 0.08% 314
2016
Q1
$254K Sell
7,256
-23,604
-76% -$762K 0.02% 697
2015
Q4
$995K Buy
30,860
+18,113
+142% +$588K 0.08% 364
2015
Q3
$412K Buy
12,747
+3,371
+36% +$127K 0.07% 446
2015
Q2
$388K Buy
9,376
+3,049
+48% +$129K 0.02% 737
2015
Q1
$284K Buy
6,327
+731
+13% +$30.6K 0.01% 721
2014
Q4
$209K Sell
5,596
-1,592
-22% -$58.3K 0.01% 722
2014
Q3
$251K Buy
+7,188
New +$256K 0.02% 640

Other funds holding HAE